{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:54:19Z","timestamp":1780080859700,"version":"3.54.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH\/NCI","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ymeth.2020.06.020","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T11:15:51Z","timestamp":1593861351000},"page":"105-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Functional imaging using radiomic features in assessment of lymphoma"],"prefix":"10.1016","volume":"188","author":[{"given":"Marius E.","family":"Mayerhoefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Umutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Sch\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymeth.2020.06.020_b0005","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"issue":"2016","key":"10.1016\/j.ymeth.2020.06.020_b0010","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymeth.2020.06.020_b0015","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymeth.2020.06.020_b0020","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/annonc\/mdx097","volume":"28","author":"Younes","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ymeth.2020.06.020_b0025","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1182\/blood.2019000719","article-title":"Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III\/IV Hodgkin lymphoma","volume":"134","author":"Stephens","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ymeth.2020.06.020_b0030","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced Hodgkin\u2019s lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ymeth.2020.06.020_b0035","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/0284186X.2018.1426877","article-title":"PET-adapted therapy for advanced Hodgkin lymphoma - systematic review","volume":"57","author":"Amitai","year":"2018","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ymeth.2020.06.020_b0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2967\/jnumed.118.210047","article-title":"Metabolic tumor volume for response prediction in advanced-stage Hodgkin lymphoma","volume":"60","author":"Mettler","year":"2019","journal-title":"J Nucl Med."},{"key":"10.1016\/j.ymeth.2020.06.020_b0045","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1200\/JCO.2016.66.9440","article-title":"Baseline metabolic tumor volume predicts outcome in high\u2013tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies","volume":"34","author":"Meignan","year":"2016","journal-title":"JCO"},{"key":"10.1016\/j.ymeth.2020.06.020_b0050","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00259-016-3315-7","article-title":"Combination of baseline metabolic tumour volume and early response on PET\/CT improves progression-free survival prediction in DLBCL","volume":"43","author":"Mikhaeel","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.ymeth.2020.06.020_b0055","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1007\/s00259-017-3776-3","article-title":"Predictive value of 18F-FDG PET\/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial","volume":"44","author":"Becker","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging."},{"key":"10.1016\/j.ymeth.2020.06.020_b0060","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2019003277","article-title":"Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 clinical trial","author":"Sch\u00f6der","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ymeth.2020.06.020_b0065","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood-2017-06-788877","article-title":"Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma","volume":"130","author":"Moskowitz","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ymeth.2020.06.020_b0070","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/bjc.2015.134","article-title":"Diffusion-weighted MRI for imaging cell death after cytotoxic or apoptosis-inducing therapy","volume":"112","author":"Papaevangelou","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymeth.2020.06.020_b0075","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s11307-019-01329-2","article-title":"Pre-therapeutic total lesion glycolysis on [18F]FDG-PET enables prognostication of 2-year progression-free survival in MALT lymphoma patients treated with CD20-antibody-based immunotherapy","volume":"21","author":"Mayerhoefer","year":"2019","journal-title":"Mol Imaging Biol."},{"key":"10.1016\/j.ymeth.2020.06.020_b0080","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","article-title":"The causes and consequences of genetic heterogeneity in cancer evolution","volume":"501","author":"Burrell","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymeth.2020.06.020_b0085","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/carcin\/bgx071","article-title":"Intratumor heterogeneity predicts metastasis of triple-negative breast cancer","volume":"38","author":"Yang","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ymeth.2020.06.020_b0090","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00259-018-4138-5","article-title":"Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer","volume":"46","author":"Moon","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging."},{"key":"10.1016\/j.ymeth.2020.06.020_b0095","doi-asserted-by":"crossref","first-page":"67302","DOI":"10.18632\/oncotarget.11693","article-title":"Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma","volume":"7","author":"Choi","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.ymeth.2020.06.020_b0100","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1158\/0008-5472.CAN-11-3943","article-title":"Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer","volume":"72","author":"Nair","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymeth.2020.06.020_b0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.crad.2016.09.013","article-title":"Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging","volume":"72","author":"Sala","year":"2017","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ymeth.2020.06.020_b0110","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2967\/jnumed.118.222893","article-title":"Introduction to radiomics","volume":"61","author":"Mayerhoefer","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ymeth.2020.06.020_b0115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"Image biomarker standardisation initiative","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology."},{"key":"10.1016\/j.ymeth.2020.06.020_b0120","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol."},{"key":"10.1016\/j.ymeth.2020.06.020_b0125","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1118\/1.3081408","article-title":"Effects of MRI acquisition parameter variations and protocol heterogeneity on the results of texture analysis and pattern discrimination: An application-oriented study: Effects of MRI acquisition parameters on texture analysis","volume":"36","author":"Mayerhoefer","year":"2009","journal-title":"Med. Phys."},{"key":"10.1016\/j.ymeth.2020.06.020_b0130","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1007\/s00259-019-04391-8","article-title":"Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis","volume":"46","author":"Zwanenburg","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.ymeth.2020.06.020_b0135","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2967\/jnumed.115.156927","article-title":"Impact of image reconstruction settings on texture features in 18F-FDG PET","volume":"56","author":"Yan","year":"2015","journal-title":"J. Nuclear Med."},{"key":"10.1016\/j.ymeth.2020.06.020_b0140","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2967\/jnumed.118.217612","article-title":"Optimized Feature Extraction for Radiomics Analysis of 18 F-FDG PET Imaging","volume":"60","author":"Papp","year":"2019","journal-title":"J Nucl Med."},{"key":"10.1016\/j.ymeth.2020.06.020_b0145","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2967\/jnumed.117.199935","article-title":"A postreconstruction harmonization method for multicenter radiomic studies in PET","volume":"59","author":"Orlhac","year":"2018","journal-title":"J Nucl Med."},{"key":"10.1016\/j.ymeth.2020.06.020_b0150","article-title":"18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma","volume":"23","author":"Kong","year":"2019","journal-title":"NeuroImage: Clin."},{"key":"10.1016\/j.ymeth.2020.06.020_b0155","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00234-018-2091-4","article-title":"Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI","volume":"60","author":"Kim","year":"2018","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ymeth.2020.06.020_b0160","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/neuonc\/noy021","article-title":"Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation","volume":"20","author":"Kang","year":"2018","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.ymeth.2020.06.020_b0165","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1038\/s41598-019-42276-w","article-title":"Radiomic features and multilayer perceptron network classifier: a robust MRI classification strategy for distinguishing glioblastoma from primary central nervous system lymphoma","volume":"9","author":"Yun","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymeth.2020.06.020_b0170","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/cam4.2711","article-title":"Radiomics based on 18 F-FDG PET\/CT could differentiate breast carcinoma from breast lymphoma using machine-learning approach: A preliminary study","volume":"9","author":"Ou","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.ymeth.2020.06.020_b0175","article-title":"Differential diagnostic ability of 18F-FDG PET\/CT radiomics features between renal cell carcinoma and renal lymphoma","author":"Zhu","year":"2019","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ymeth.2020.06.020_b0180","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00259-017-3899-6","article-title":"Diagnostic and prognostic value of baseline FDG PET\/CT skeletal textural features in diffuse large B cell lymphoma","volume":"45","author":"Aide","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.ymeth.2020.06.020_b0185","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3390\/cancers12051138","article-title":"Sch\u00f6der, [18F]FDG-PET\/CT radiomics for prediction of bone marrow involvement in mantle cell lymphoma: a retrospective study in 97 patients","volume":"12","author":"Mayerhoefer","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ymeth.2020.06.020_b0190","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1148\/rg.301095088","article-title":"FDG PET\/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease","volume":"30","author":"Paes","year":"2010","journal-title":"Radiographics"},{"key":"10.1016\/j.ymeth.2020.06.020_b0195","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","article-title":"Prognostic value of Ki-67 Index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the european mantle cell lymphoma network","volume":"34","author":"Hoster","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymeth.2020.06.020_b0200","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41598-018-37197-z","article-title":"A PET radiomics model to predict refractory mediastinal hodgkin lymphoma","volume":"9","author":"Milgrom","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymeth.2020.06.020_b0205","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1097\/RLU.0000000000002732","article-title":"Prognostic value of pretreatment radiomic features of 18F-FDG PET in patients with Hodgkin lymphoma","volume":"44","author":"Lue","year":"2019","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.ymeth.2020.06.020_b0210","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12149-018-1260-1","article-title":"18F-FDG PET\/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin\u2019s lymphoma as predictors of treatment outcome and survival","volume":"32","author":"Parvez","year":"2018","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.ymeth.2020.06.020_b0215","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1007\/s00259-019-04420-6","article-title":"Radiomic features of glucose metabolism enable prediction of outcome in mantle cell lymphoma","volume":"46","author":"Mayerhoefer","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging."},{"key":"10.1016\/j.ymeth.2020.06.020_b0220","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-020-06815-8","article-title":"Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy","author":"Aide","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ymeth.2020.06.020_b0225","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-020-06943-1","article-title":"Development and validation of an 18F-FDG PET radiomic model for prognosis prediction in patients with nasal-type extranodal natural killer\/T cell lymphoma","author":"Wang","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ymeth.2020.06.020_b0230","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2967\/jnumed.119.235325","article-title":"The dark side of radiomics: on the paramount importance of publishing negative results","volume":"60","author":"Buvat","year":"2019","journal-title":"J. Nucl. Med."}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202320301353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202320301353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:40:29Z","timestamp":1760924429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202320301353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":46,"alternative-id":["S1046202320301353"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2020.06.020","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional imaging using radiomic features in assessment of lymphoma","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2020.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}